If you have any question, please feel free to email us. We will touch with you as soon as possible.
Name: Dexrazoxane
Chinese Name: 右雷佐生
CAS. No.: 24584-09-06
Molecular Formula: C11H16N4O4
Molecular Weight: 268.27 g/mol
Source: India
Qualifications: USDMF/-/-/-/-
Name | Dexrazoxane |
Chinese Name | 右雷佐生 |
CAS. No. | 24584-09-06 |
Molecular Formula | C11H16N4O4 |
Molecular Weight | 268.27 g/mol |
Source | India |
Qualifications | USDMF/-/-/-/- |
Dexrazoxane was developed by Chiron Corporation of the United States, first launched in Italy in 1992, and approved by FDA in July 1995. It was subsequently launched in Europe, Asia, Africa and other countries. Dexrazoxane is clinically indicated for the prevention of anthracycline-induced cardiotoxicity. Dexrazoxane is the d-isomer of racemic razoxane and a lipophilic derivative of the chelating agent ethylenediaminetetraacetic acid, which can quickly penetrate the cell membrane and reduce the cardiotoxicity of anthracycline antitumor antibiotics such as doxorubicin, Dexrazoxane is hydrolyzed into TCRE-198 in the cell and then chelated with intracellular iron, reducing the complexity of ferric ion and doxorubicin and other anthracycline antineoplastic drugs, preventing the formation of free radicals and take effect.
Dexrazoxane is currently the only clinically approved drug for the prevention of cardiotoxicity of anthracyclines. Clinical trials in European and American countries have shown that this drug is expected to become a standard compatible drug for anthracycline antineoplastic drugs. Although dexrazoxane is currently mainly used to prevent anthracycline-induced cardiotoxicity, its potential in regulating topoisomerase II activity and cellular iron metabolism will be used in cancer treatment, immunology, infectious diseases, etc. in the future. Aspects of application will likely become the focus.
For more information please feel free to get in touch with us today!
Email: tonghuiyy218@upharm.cn
Wechat/WhatsApp: +86-189-2212-0635
Hot Tags: dexrazoxane api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Solinasine Succinate API, Brinzolamide API, Cinacalcet Hydrochloride API, Troxagliptin Succinate API, Tippyridine Hydrochloride API, Gabapentin API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China